Search

Your search keyword '"Immune correlates"' showing total 276 results

Search Constraints

Start Over You searched for: Descriptor "Immune correlates" Remove constraint Descriptor: "Immune correlates"
276 results on '"Immune correlates"'

Search Results

1. Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses.

2. Serum and mucosal antibody-mediated protection and identification of asymptomatic respiratory syncytial virus infection in community-dwelling older adults in Europe

3. COVID-19 vaccines: Immune correlates and clinical outcomes

4. Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses

5. Importance of adjuvant selection in tuberculosis vaccine development: Exploring basic mechanisms and clinical implications

6. Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines.

7. Animal Models for Studying Congenital Transmission of Hepatitis E Virus.

8. Molecular mechanisms of Coxiella burnetii formalin-fixed cellular vaccine reactogenicity.

9. COVID-19 vaccines: Immune correlates and clinical outcomes.

10. Analysis of Neutralizing Antibodies as a Correlate of Instantaneous Risk of Hospitalized Dengue in Placebo Recipients of Dengue Vaccine Efficacy Trials.

11. Predictive value of TNF-α, IFN-γ, and IL-10 for tuberculosis among recently exposed contacts in the United States and Canada

12. Vaccine Development for Cytomegalovirus

13. Forward Stepwise Deep Autoencoder-Based Monotone Nonlinear Dimensionality Reduction Methods.

14. HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy

15. Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes

16. Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.

17. Next-Generation Influenza Vaccines

18. Predictive value of TNF-α, IFN-γ, and IL-10 for tuberculosis among recently exposed contacts in the United States and Canada.

19. Innovations in HIV-1 Vaccine Design.

20. Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses.

21. Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.

22. Immunoprofiling of peripheral blood from infectious bronchitis virus vaccinated MHC-B chicken lines – Monocyte MHC-II expression as a potential correlate of protection.

23. Immune Correlates of Protection Induced by Virus-Like Particles Containing 2009 H1N1 Pandemic Influenza HA, NA or M1 Proteins.

24. Immune Correlates of Protection From West Nile Virus Neuroinvasion and Disease.

25. Can Ebola Virus Vaccines Have Universal Immune Correlates of protection?

26. Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine Immunity

27. Role of Opsonophagocytosis in Immune Protection against Malaria

28. Importance of adjuvant selection in tuberculosis vaccine development: Exploring basic mechanisms and clinical implications.

29. Protective efficacy and correlates of immunity of immunodominant recombinant Babesia microti antigens.

30. Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines.

31. Correlates of immune and clinical activity of novel cancer vaccines.

32. HIV Vaccination: A Roadmap among Advancements and Concerns.

33. Peripheral immune correlates of childhood and adolescent peer relationships: A systematic review

34. Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need

35. Is mapping the BCG vaccine‐induced immune responses the key to improving the efficacy against tuberculosis?

36. Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.

37. The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis.

38. Approaches and Challenges in SARS-CoV-2 Vaccine Development

39. Immune signatures underlying post-acute COVID-19 lung sequelae

40. HIV Vaccination: A Roadmap among Advancements and Concerns

41. Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.

42. Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination.

43. The Immune Correlates of Orthohantavirus Vaccine

44. Immunoprofiling of peripheral blood from infectious bronchitis virus vaccinated MHC-B chicken lines – Monocyte MHC-II expression as a potential correlate of protection

45. Moving the HIV vaccine field forward: concepts of protective immunity

46. Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition

47. HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy

48. Can Ebola Virus Vaccines Have Universal Immune Correlates of protection?

49. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells

50. Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection

Catalog

Books, media, physical & digital resources